Get started
BAYN: Long (end of cycle + support)Hello everyone!!! Bayer AG at the channel support. There is hope for the end of the bearish trend that began in 2015. Additionally, according to the cyclical analysis, we can see the completion of a cycle of 1610 days (or 230 weeks, or 4.5 years). The cycle was repeated 7 times: of which 5 times there was an increase in the share price and 2 times - a fall. Therefore, this time too, we can expect the price to rise at least to the slope and horizontal resistance lines - about € 79 or 70% = take profit. My stop loss is set at € 42.610 (about -12% and 3% below the last local low). As for the indicators, the background is bullish. However, there was a huge bullish gap in 1996 and it has not been closed until now .... I plan to increase my position using the pyramiding method. Not a recommendation, not advice. I wish everyone a lot of profit !! PS Bayer AG - is a German multinational pharmaceutical and life sciences company and one of the largest pharmaceutical companies in the world. Headquartered in Leverkusen, Bayer's areas of business include human and veterinary pharmaceuticals; consumer healthcare products; agricultural chemicals, seeds and biotechnology products. The company is a component of the Euro Stoxx 50 stock market index. Werner Baumann has been CEO since 2016. Founded in Barmen in 1863 as a dyestuffs factory, Bayer's first and best-known product was aspirin. en.wikipedia.org
XETR:BAYNLong
by Dr_Chester
1
Verbio did! Analysis retrospective.After having analzed Ver.bio stocks a couple months ago, involving a Fib Retracement, Pitchfork Schiff and a Head&Shoulders, I finally sold and can take a resumé of my (back in the day) first analysis. I used the Fib Retracement (indicated by the golden break) to determine a perfect entry point for the stock. I quickly bought after we surpassed the golden break. Regarding the Pitchfork Schiff, its on point. Nothing else to say, really surprised how well this worked out. The proposed head&shoulders missed and I need to admit that I acutally misplaced them completely. I still don't really know, how to place them properly; its just experience I assume. But I need to mention, that Ver.bio has modeled a absolutely beautiful curve in the last months and its obviously not my analysis, that made that happen. Could have gone way worse from the back in the day-perspective. The instruments I tested in this case worked really well for me, dispite the accident with the H&S - I gonna rethink that in future analyses. Good luck, have fun! GRDN
XETR:VBKLong
by GRDN
Tui Short but buy soonTui failed to continue its head and shoulders pattern due to a surprise share offering! thanks for that tui. this clearly shows they are still struggling which is obvious but this means continued downside for tui is expected especially over the winter. we might get a decent earings out around september next year which will boost share price. from here now considering the offering allowed shareholders to buy at 182 there will be selling upon issue of these shares lowering share price to bottom support line in my opinion around 180/140. i consider this a buy area and can see the failing wedge pattern play out next year so lower your average down and buy anything under 150 if you get the chance. i see travelling becoming hot in late 2022 and in 2023 and this will be the beginning of a trend. during this time no doubt the stock market will flop which will allow people to get a good temporary deal on tui and people decide to spend some profits on holidays. the rotation is coming and tui are the leader and basically only major holiday maker left in UK
XETR:TUI1Long
by JamesFlem
Lamda Developments AnalysisFor the Margin of Safety I used: Basic EPS 2020: 1.01 Possible EPS Growth: 15% Discount Rate: 9% A few data that makes me think it could be a good investment is that they just started getting income from the old airport Elliniko which they made it into new Villas and Office centers. So that should give them a better income for the next years. While the margin of safety is very low than the current price. I would wait for some weeks to see if it brakes a small resistance or its support to judge accordingly. the price will drop eventually the next months to its Margin of safety price and rise from the begining of the 2nd quarter of 2022... I'm a bad analyst with very small experience... Let's see what happens
SWB:LDQ
by Kontopodis_Emm
Tui Analysis 09.10.2021Hello Traders, welcome to this free and educational analysis. I am going to explain where I think this asset is going to go over the next days/weeks and where I would look for trading opportunities. If you have any questions or suggestions which asset I should analyse tomorrow, please leave a comment below. I would also appreciate, if you would smash that like button and help me to create more free analysis like that. Thank you for watching and I will see you tomorrow!
XETR:TUI1
by basictradingtv
1
MORPHOSYS MORPHOSYS had a very strong sell and decline within the last months. Many reasons, two are more important: The cancer drug "Monjuvi" is in delay and apparently there have been troubles in the scientifical research. Secondly, Constellation Pharmaceuticals bought MOR for billions of dollars, a takeover that did not effect the price-action in a positive way. These are the background news, more or less! Technical Analysis is simple. Super-overbought on Daily and weekly chart on the RSI with a bullish divergence on both, daily and weekly. We probably found a bottom here. On the smaller timeframe, 4h, we have a bullsih div with an eventual Adam&Eve reversal. Red is my target with 70% sell, rest is stoploss above entry and see where MOR might goes! No financial advice, just my point of view
MLong
by FloTi